Atıf İçin Kopyala
Gibson C. M., Chi G., Halaby R., Korjian S., Daaboul Y., Jain P., ...Daha Fazla
CIRCULATION, cilt.135, sa.7, ss.648-655, 2017 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
135
Sayı:
7
-
Basım Tarihi:
2017
-
Doi Numarası:
10.1161/circulationaha.116.025427
-
Dergi Adı:
CIRCULATION
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.648-655
-
Anahtar Kelimeler:
anticoagulants, cardiology, cardiovascular diseases, intracranial hemorrhages, stroke, thrombosis, WARFARIN, OUTCOMES, CARE
-
Hacettepe Üniversitesi Adresli:
Evet
Özet
BACKGROUND: Stroke is a morbid and potentially mortal complication among patients hospitalized with acute medical illness. The potential of extended-duration thromboprophylaxis with the factor Xa inhibitor betrixaban to reduce the risk of stroke compared with standard-dose enoxaparin in this population was assessed in this retrospective APEX trial substudy (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban).